drugset / Trial / NCT01305538
Crossover Post-herpetic Neuralgia (PHN)
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of the study is to evaluate the efficacy of study drug (BMS-954561) as compared to placebo in the treatment of patients with post-herpetic neuralgia (PHN).
Timeline
- Start
- 2011-03
- Primary completion
- 2012-02
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-954561 | Unknown | 40 mg | — |
| Subject | BMS-954561 | Unknown | 80 mg | — |
| Subject | BMS-954561 | Unknown | 150 mg | — |
| Subject | BMS-954561 | Unknown | 300 mg | — |